Physician profile
Lisa Rounds
NPI 1376979815
$1,309.84
in general payments reported to CMS, 2019-2025
17 companies · $338 in 2025
The $338 reported for 2025 was more than what 87% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $73.03 · 2022: $316 · 2023: $297 · 2024: $286 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $920.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $223.61 | 2022-2025 | |
| Ironshore Pharmaceuticals INC. | $222.00 | 2022-2024 | Jornay Pm |
| Sanofi Pasteur INC. | $188.96 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $110.22 | 2025 | Jornay Pm |
| Glaxosmithkline, LLC. | $95.95 | 2022-2025 | Bexsero, Rotarix |
| Ultragenyx Pharmaceutical INC. | $81.12 | 2022-2024 | Crysvita |
| Phadia US INC. | $68.54 | 2021-2023 | Immunocap |
| Cranial Technologies, INC | $62.98 | 2022-2025 | Doc Band |
| Corium, LLC | $55.96 | 2021-2023 | Azstarys |
| Merck Sharp & Dohme LLC | $40.51 | 2024-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Sobi, INC | $38.03 | 2021-2022 | |
| Biomarin Pharmaceutical INC. | $37.67 | 2025 | Voxzogo 1.2mg |
| Takeda Pharmaceuticals U.S.A., INC. | $20.21 | 2022 | |
| Kyowa Kirin, INC. | $19.19 | 2025 | |
| Nestle Healthcare Nutrition INC. | $16.16 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $14.90 | 2023 | |
| Hologic Sales and Service, LLC | $13.83 | 2023 | Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Rounds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.